Journal
ONCOLOGY LETTERS
Volume 21, Issue 4, Pages -Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/ol.2021.12599
Keywords
bone cancer pain; mechanical allodynia; dorsal root ganglia; Epac1-Piezo2 pathway; NR2B
Categories
Funding
- National Natural Science Foundation of China [81500951, 81870875]
- Six Talent Peaks Project of Jiangsu Province [YY-077]
- Young Medical Talents of Jiangsu Province [QNRC2016014]
- Fundamental Research Funds for the Central Universities [021414380014]
Ask authors/readers for more resources
The study demonstrated that the Epac1-mediated Piezo2 signaling pathway in bone cancer pain may involve the downstream regulator NR2B, contributing to the development of mechanical allodynia. The findings provide insights into potential analgesic strategies for clinical treatment of bone cancer pain.
Mechanical allodynia is a painful perception of mechanical stimuli and one of the typical symptoms in bone cancer pain (BCP). Previous studies have revealed that mice and humans lacking mechanically activated Piezo2 channels do not sense mechanical stimuli. However, the underlying mechanism of Piezo2 in BCP has not been well established. The aim of the present study was to investigate whether exchange protein directly activated by cAMP 1 (Epac1) mediated Piezo2 signaling pathway may be responsible for the mechanical allodynia of BCP and whether N-methyl-D-aspartic acid (NMDA) receptor subunit 2B (NR2B) is involved in the pathway. In the present study, a BCP model was established in C3H/HeJ mice by intramedullary injection of osteosarcoma cells. The results of the mechanical allodynia test demonstrated a markedly decreased paw withdrawal mechanical threshold in BCP mice, accompanied by a significant increase in Epac1, NR2B proteins and Piezo2 mRNA expression levels in the ipsilateral dorsal root ganglion (DRG). Compared with the sham group, intrathecal Epac1 antisense oligodeoxynucleotides (Epac1-ASODN) effectively ameliorated the mechanical allodynia and decreased the expression levels of NR2B and Piezo2 in the tumor group. Pretreatment of naive mice with a NR2B antagonist prevented the aggravation of mechanical allodynia and DRG Piezo2 levels induced by an Epac1 agonist. However, the NR2B agonist-induced increase in Piezo2 expression levels was not reversed by pretreatment with Epac1-ASODN. In conclusion, the results of the present study demonstrated that NR2B, which is a crucial downstream regulator of Epac1, may mediate the Epac1-Piezo2 pathway contributing to the development of the mechanical allodynia of BCP. The present study may enrich the theoretical knowledge of the mechanical allodynia of BCP and provide a potential analgesic strategy for clinical treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available